Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?

Andrew Udy; Cecilia Covajes; Fabio Silvio Taccone; Frédérique Jacobs; Jean Louis Vincent; Jeffrey Lipman; Jason A. Roberts

doi:10.1016/j.ijantimicag.2013.01.018

Back

Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?

Article 2013 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2015

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy

IA Crippa, Joseph G. Gleeson, V. Fontana, Jean Louis Vincent, Jacques Créteur, FS Taccone

Article2011

Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens

Jason A. Roberts, Fabio Silvio Taccone, Andrew Udy, Jean Louis Vincent, Frédérique Jacobs, Jeffrey Lipman

Article2010

Vancomycin Dosing in Critically Ill Patients Using Population Pharmacokinetics to Develop Personalised Dosing Regimens to Achieve Target Concentrations by Continuous Infusion

Jason A. Roberts, Fabio Silvio Taccone, Andrew Udy, Jean Louis Vincent, Frédérique Jacobs, Jeffrey Lipman

Article2013

Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy

Cecilia Covajes, Sabino Scolletta, Laura Penaccini, Eva Ocampos-Martinez, Ali Abdelhadii, Marjorie Beumier, Frédérique Jacobs, Daniel De Backer, Jean Louis Vincent, Fabio Silvio Taccone

Article2011

Continuous infusion of vancomycin in septic patients on continuous renal replacement therapy

Cecilia Covajes, Daniel De Backer, Eva Ocampos-Martinez, Laura Penaccini, Ali Abdelhadii, Frédérique Jacobs, Jean Louis Vincent, Fabio Taccone